Send me real-time posts from this site at my email

Blueprint Medicines (BPMC) Set to Acquire Lengo Therapeutics

Blueprint Medicines (BPMC) inks an agreement to acquire privately held Lengo Therapeutics. The company is looking to boost its lung cancer portfolio with this acquisition.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue